Nonviral skin gene therapy

Human Gene Therapy

Volumn 11, Issue 16, 2000, Pages 2253-2259

  Vogel, J C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CHIMERIC PROTEIN; INTERLEUKIN 12;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; NONHUMAN; PROTEIN TRANSPORT; TH1 CELL; TH2 CELL; TUMOR REGRESSION;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DNA; EPIDERMIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; ISLETS OF LANGERHANS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0034329457     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303400750035780     Document Type: Article

References (56)

1. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major
2. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
3. Liposome-mediated gene transfer and expression via the skin
4. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair
5. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
6. Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells
7. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
8. Direct cutaneous gene delivery in a human genetic skin disease
9. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
10. DNA-based immunization by in vivo transfection of dendritic cells
11. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
12. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex
13. Targeting the skin for genetic immunization
14. Immunization via hair follicles by topical application of naked DNA to normal skin
15. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
16. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
17. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience
18. Cytokine gene expression in epidermis with biological effects following injection of naked DNA
19. Expression of naked DNA in human, pig, and mouse skin
20. Liposome-mediated gene transfer into human basal cell carcinoma
21. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-lipsome complexes
22. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
23. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
24. Effect of multiple gene transfers of insulin-like growth factor 1 complementary DNA gene constructs in rats after thermal injury
25. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma
26. CpG motifs in bacterial DNA trigger diret B-cell activation
27. The feasibility of targeted selective gene therapy of the hair follicle
28. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvant
29. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: Functional and morphologic studies
30. Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin
31. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
32. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo
33. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA
34. Immune activation by bacterial DNA: A new genetic code
35. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors
36. Introduction: Gene vaccination, current concepts, and future directions. Springer Semin
37. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
38. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
39. The regulation of immunity to Leishmania major
40. In vivo electrically mediated protein and gene transfer in murine melanoma
41. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
42. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
43. DNA-based non-invasive vaccination onto the skin
44. The dendritic cell system and its role in immunogenicity
45. DNA as an adjuvant: Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen
46. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice
47. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin
48. Genetic immunization is a simple method for eliciting and immune response
49. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds
50. A direct in vivo approach for skin gene therapy
51. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell-type 1 immune response and protection in a murine model of leishmaniasis
52. Immunostimulatory oligonucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12 and IFN-γ-dependent mechanisms
53. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
54. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
55. Genetic vaccines - A revolution in vaccinology?
56. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment